Welcome
Support Centre
21 May 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
A double blind RCT of selective supraomohyoid neck dissection with/without level 2b for node negative oral cancer and resulting shoulder function
ISRCTN ISRCTN22424487
ClinicalTrials.gov identifier
Public title A double blind RCT of selective supraomohyoid neck dissection with/without level 2b for node negative oral cancer and resulting shoulder function
Scientific title
Acronym N/A
Serial number at source N0025177121
Study hypothesis The aim of the project is to compare patient derived and clinician rated morbidity, in terms of shoulder function, following a selective 1-3 level neck dissection in two groups of patients randomised for inclusion of level 2b in the neck and shoulder.
Lay summary Not provided at time of registration
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Cancer: Head and neck
Participants - inclusion criteria 1. Patients with previously untreated oral cancer arising from the floor of the mouth and anterior two thirds of tongue who are neck node negative both clinically and on MRI scan.
2. Requiring selective 1-3 level neck dissection as part of their overall treatment plan.
Participants - exclusion criteria Not provided at time of registration
Anticipated start date 01/01/2006
Anticipated end date 01/01/2009
Status of trial Completed
Patient information material Not available in web format, please use the contact details below to request a patient information sheet
Target number of participants 60
Interventions This will be a pilot study for a double blind randomised controlled trial. 60 patients requiring selective 1-3 level neck dissection as part of their overall treatment plan would be randomised as to whether they have a level 2b or not.

Assessment will be at 3 points: baseline, six weeks post operatively and 6 months. There will be monitoring for 2 years using existing follow-up protocols for neck node recurrence. Assessment will include: neurophysiology examination, clinical examination, self-completed questionnaires.
Primary outcome measure(s) Not provided at time of registration
Secondary outcome measure(s) Not provided at time of registration
Sources of funding Aintree Hospitals NHS Trust (UK)
NHS R&D Support Funding
Trial website
Publications
Contact name Dr  Stanley  Parikh
  Address AintreeTrust
University Hospital Aintree
Lower Lane
  City/town Liverpool
  Zip/Postcode L9 7AL
  Country United Kingdom
  Tel +44 0151 529 5283
  Fax +44 0151 529 5288
  Email stanp@doctors.org.uk
Sponsor Record Provided by the NHSTCT Register - 2006 Update - Department of Health
  Address The Department of Health, Richmond House, 79 Whitehall
  City/town London
  Zip/Postcode SW1A 2NL
  Country United Kingdom
  Tel +44 (0)20 7307 2622
  Email dhmail@doh.gsi.org.uk
  Sponsor website: http://www.dh.gov.uk/Home/fs/en
Date applied 29/09/2006
Last edited 09/05/2012
Date ISRCTN assigned 29/09/2006
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central